22 May 2013
Keywords: Strativa, FDA, USA, Zuplenz, Par Pharma, MonoSol Rx, milestone
Article | 05 July 2010
Strativa Pharmaceuticals, a unit of Par Pharmaceuticals, announced on Friday that the US Food and Drug Administration had approved Zuplenz ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2010
6 July 2010
21 May 2013
© 2013 thepharmaletter.com